Though liver and kidney‐related indicators of ALT, aspartate aminotransferase (AST), gamma‐glutamyl transpeptidase (GGT), uric acid, and urea were upper than the normal range in SARS‐CoV‐2 infected patients with concomitant liver diseases, no significant difference was observed between azvudine and control groups except for few time points. The gene discussed is GGTLC1; the disease is liver disorder.